RE: Half year results...16 Jan 2021 13:07
Ive done some rns... READING for you
At year end over £1.0m of initial orders for Genedrive® 96 SARS-CoV-2 kit, pending regulatory approvals
· Post year end, no material sales for 96 SARS-CoV-2 test as we await further registrations, but further orders are anticipated through a widened network of partners. Pipeline includes an advanced opportunity for supply to a Ministry of Health of a European country, which if converted to a sale, could be for low double digit millions of pounds and delivered in the first quarter of 2021